Evaluation of Efficacy and Safety of Curalin As Add-On Therapy in Adults With Type 2 Diabetes Mellitus
A phase 2 trial registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 135 participants.
Also called NCT05631431
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose supportive care
- Phase
- Phase 2
- Enrolled
- 135 participants
- Sponsor
- CuraLife
- Registry
-
NCT05631431
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Israel
- Registry status
- Terminated
Technical summary
Registry record NCT05631431. Randomized; triple masking; primary purpose supportive care. Start 2021-12-14 (actual); primary completion 2023-06-29 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Evaluation of Efficacy and Safety of Curalin As Add-On Therapy in Adults With Type 2 Diabetes Mellitus
- Condition
- Type2 Diabetes
- Intervention (Dietary supplement)
- Curalin
- Lead sponsor
- CuraLife
Record details
- Record id
cardio:ct-nct05631431- Content hash
5aa3a71263065b0b2d297a347da9d7db8357e985805356858b4eacd8c20f73f3